NEW YORK, Dec 13 - Incyte Genomics said Wednesday it has formed two genomic research partnerships with leading academic institutions to study common diseases.

The company is partnering with the University of California San Francisco to study prostate cancer, and with CARIM, the Maastricht Cardiovascular Research Institute in the Netherlands to study cardiovascular disease.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.